BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)
Old Forum Content for BCRX
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- sierramp: Watching $BCRX It got an upgrade to Outperform from Brian Abrahams at RBC with PT of $9 to $10. Abrahams has an 80% accuracy rate with his calls. $BCRX has a ROE of 77.4% which is pretty rare with biotechs. The company develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases.
- Motorman: @Woodman Take a look at old fave $BCRX
- woodman: @Motorman $BCRX - not bad, but chartwise (similar move) I like $SRPT better with big gap still to fill.
- woodman: $BCRX - follow the bouncing ball. Could be ready for next move up.
- Motorman: $BCRX Day 2, @Woodman...where's your Mojo!
- woodman: @Motorman $BCRX - Saw it yesterday but didn't react. "Danger" used to be my middle name.
- roddog101: Scott/Dan/& other technical guys What do you guys think of $BCRX? They have a new (been out for less than yr HAE drug that competes w $TAK, one of the most expensive drugs on market, but not a huge huge patient population, but growing) Others are working to bring HAE drugs as well. Had this one and sold a while back before the bigger swoon. The next in pipeline is suppose to be a big dollar drug but a ways away. Here is chart, ma crossovers etc. Would this one even come close to last nights criteria? https://elite.finviz.com/published_idea.ashx?t=BCRX&f=122321&i=BCRXd134895615i
- scottrades: @roddog101 $BCRX $TAK I typically like to buy stocks coming out of bases and above all the major MAs. Those are my most reliable setups.
- roddog101: @scottrades $BCRX $TAK thanks
- roddog101: $BCRX nearing 200 day,, Thinking it bounces soon
- roddog101: Some saying $BCRX down on $MRK news. I dont think I buy that as BCRX isnt putting any funds toward antiviral right now. I think BCRX worth a swing long here to reclaim 100 day or better by time ER comes in Nov. Got 10 ITM calls at 4.00 to not take up as much capital.
- DrScience: @roddog101 $BCRX Disregarding any abundance or lack of good sense or judgment on your part, I ask what is your strategy for maximizing profit while minimizing risk? The weekly chart is showing a little different story from the daily, so clearly, any ...
- Pokersmith: @DrScience $BCRX Such a great post. 👍 Thanks for sharing your insights. " option premium collection strategy " 👍👍👍
- Henry: @DrScience $BCRX I have a bunch of lines and notations from when I owned this pig in 2014. They have a drug for hereditary angioedema. All the doctors in this forum raise your hand if you've ever seen a case.........I have not. no doubt they are w ...
- Pokersmith: @DrScience $BCRX I'm assuming you meant "selling", not buying a covered call, OR did you mean buying a call, not a covered one.
- DrScience: @Pokersmith $BCRX It seems somewhat counter-intuitive to buy a Covered Call since you're actually selling the call to cover stock. But, since you have to buy the stock before you can sell the call, you buy the stock at a reduced price.
- woodman: $BCRX interesting on the weekly
- roddog101: Looking for feedback on this setup, blast me & tell me how stupid I am $BCRX https://elite.finviz.com/published_idea.ashx?t=BCRX&f=083121&i=BCRXd221130604i
- woodman: $BCRX - puking out the bottom of the range. I had "hoped" this would hold the range, but hope doesn't cut it. That's why we have stops.
- woodman: $BCRX - following Tuesday's drop, this has continued to hold the bottom of its 2.5 month sideways consolidation range. I added the other day with a stop, which is easy to see. The weekly is intact.
- woodman: $BCRX - bad day due to $200 million offering. Today's thwacking brings it to the bottom of its nearly 2.5 month sideways range. Watch for opportunity here. Weekly is still intact.
- Motorman: @woodman $BCRX Holding small profitable piece, did not put stop under 50D, would have got me out $1 above...will add when bounces.
- woodman: $BCRX - trying to escape its sideways range.
- lostsheep: @woodman $BCRX thanks for bringing it back to my attention. was alerted this am and lost track of it.
- woodman: $BCRX - big bullish engulfing, with big volume, on earnings report this morning. Move right up to top of 2 month sideways action into rising 50 day.
- lostsheep: $BCRX bullish engulfing 2 prior months
- woodman: @lostsheep $BCRX - bought this one back yesterday on bounce off 50d. I like the no-drama sideways drift into the rising 50d.
- woodman: $BCRX - sideways move into rising 50 day. Worth keeping an eye on.
- roddog101: $BCRX down because $NTLA has a HAE indication in pipeline,, seems to be not even close to a ph 1 to me tho
- roddog101: $BCRX nice bounce
- roddog101: any TA specialist want to give me their read on what phase $BCRX is in?
- snowbound: @roddog101 $BCRX Transactional Analysis ? Games Traders Play ?
- roddog101: @snowbound would like to know more about that GMMA, but links in article were broken. $BCRX has a reputation of being manipulated, not sure why that is, maybe the high institutional support or that stupid merger that Baker bros tried to arrange?? I never got the thesis from anyone but seen tons of respected investors/traders say that.. To me if I am a institutional holder I want it to go up,, but these guys act like the tutes have kept a lid on BCRX,, I never got it
- snowbound: @roddog101 $BCRX I didn't study this article tightly but it sounds like the SMM GAMEPLAN to me . I think any discussion DAN lays out concerning INSTITUTIONAL buying-selling and support is relevant here and probably is on your chart as well . I'll look into this more but , admittedly ... I can't help you on your level of fundamental analysis , apologies . I think you are laying out a case for a GAME of one sort or another in play whether Pump and Dump or Hide and Seek . It made the pivot at 16.73 which is also highly relevant on the WEEKLY chart . A WEEKLY flag may result but it seems early in the pattern with the 8EMA WEEKLY somewhat extended . It ran above the upper BOLLINGER Band for 3x WEEKLY's but now has fallen back inside . TIME may be in order . 16.73 would be a cautionary add .
- roddog101: @snowbound you think $BCRX is under that type of accumulation now?
- snowbound: @roddog101 $BCRX It found a pivot higher . I'll do some homework and check back . Will
- roddog101: @snowbound $BCRX I found why $BCRX had the weird vol action, it was just the Russell rebalance stuff is all.
- snowbound: @roddog101 $BCRX I see INSTITUTION VOLUME days on 04.15 as it passed through the AVWAP - 01.01.21 . The 20SMA and the 50SMA DAILY . Again on 05.06 with support at the 50 and on 05.27 and 05.28 combined (pre re balance ) . Presently its at the 8EMA support with the 20SMA very close below . Its in a flag-wedge bracketed by the 20 and the ATH that creates an M top . Its building off the support pivot lifted by the 20 ( nice ) . Volume at the 20 or at the BO level 17.50 would also show more INSTITUTIONAL support at those levels . BIG GREEN CANDLES ON HIGH VOLUME is the tell . S2 = 16.50 . R1 = 17.50 .
- roddog101: $BCRX hod, possible buyout name, shocked a big pharma hasnt already scooped it up
- Motorman: @roddog101 $BCRX Great News! thanks
- roddog101: is ah vol on $BCRX correct at 6.8 million shares traded in ah??? If so thats a huge amount for BCRX isnt it??
- Henry: @roddog101 $BCRX Edit Just saw your previous post about buyout rumors. I did not see those on twitter, but they may exist. Nasdaq says 5.2 mi but still huge volume, which is being questioned on twitter. Looks like it hit a high of 17.50 and pulled back to 17.1. They specialize in treatments for diseases most doctors never have seen the business plan being to charge an arm and a leg. There was a pt increase to $21 and they appeared at a JPM conference call Wednesday. TOS won't load but I have a vague memory of owning this pig in the past. I'm pretty sure I lost money on it. Maybe somebody knows something or maybe it's a pump and dump by a newsletter. Without any news, the volume is non-actionable. On bad study, published after hours, can torpedo a biotech.
- roddog101: @Henry $BCRX I dont think its a pump/dump. Followed this one a good while and seems to be somewhat de-risked w the HAE drug approved, I do know they surprised the street w amount of drug already sold so soon. Many are betting the next ER will again surprise w even more than expected patients taking this drug. $TAK and one other co currently have injections for this terrible disease as BCRX is oral. $TAK drug for this is one of the more expensive drugs on the market (maybe around 400-500k per year I forget exact numbers). I have been long a since 3-$4.00 and added along the way. But believe it finally may be $BCRX time to shine. Hope so anyway, I never see this kind of ah vol tho...
- CraigReynolds: Premarket movers $KSU +17.8% $TBA 7.2% $SBLK 6.1% $SNX 5.6% $BCRX 5.4% $MVIS 4.4% $TSLA 4.2% $DQ 4.1% $CHWY 4.0% $GRWG 3.7% $LAZR 3.6% $ASML 3.5% $BNGO 3.4% $APPS 3.1% $VUZI 3.0% $NIO 3.0% $RLX -36.4% $BBVA -6.3% $JBLU -4.8% $CLVS -4.1% $CUK -3.4% $CP -3.3%
- coldevinc: $BCRX Mulling over starting a position here. Have been seeing consolidation.
- DBones808: $BCRX up double digits for the third day in a row.
- DBones808: $BCRX
- Bwhitty: $BCRX added at VWAP
- Bwhitty: $CYBR $BCRX $PENN decent trades to day on all 3 and wondering if there are any strong reasonings to hold over night? That is one of the hardest decisions for me right now at my current experience level.
- Mikev200: @Bwhitty $CYBR $BCRX $PENN On my $Penn I will hold overnight. I am asking myself more recently why NOT hold overnight. Just a general thought. Stop bout $18.38.
- Bwhitty: @Mikev200 $CYBR $BCRX $PENN $Penn Thx appreciated.
- champ: @Bwhitty $CYBR $BCRX $PENN ---- I will be swinging $CYBR, for sure and I added today.
- Bwhitty: @champ $CYBR $BCRX $PENN Thx, my cushion is a lot smaller then yours I think.
- Sher: $BCRX - "Jumpin" - Lead corona player, today - Stock up 16% - ER beat, Wed. - Long May $4.00 calls, which are up 154%, currently.
- crank: @Sher $BCRX does it have major pharma cross agreements ?
- Sher: Taking profits on several day/swing trades (May options): $CRM, $CRWD, $DOCU, $QCOM, $TGT, $XLC, and $BCRX (just now) - Having a hard time wrapping my head around this market!
- Amykris: @Sher $CRM $CRWD $DOCU $QCOM $TGT $XLC $BCRX totally agree, tough to figure it out, but profits are great. Congrats
- Sher: $BCRX - Upgraded to Overweight with a $7 (78% upside) price target at Barclays. Shares up 6% premarket. Long May $4.00 calls...
- :
- CdrJake: @Sher $BCRX Galidesivir is not a vaccine. It is an antiviral drug, and in fact is an adenosine analog, similar to remdesivir, so same family, expectation would be same effect.
- Sher: $OPK - News update: ELMWOOD PARK, N.J., April 29, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Under an agreement with New York State, BioReference will begin testing thousands of people per day for COVID-19 antibodies, starting today with MTA employees. Great L/R chart - Walking up the 8-day - Just crossed above WVAP - ER on the 5th., A/C - Today's news should boost earnings run - Very long and adding to May $2.00 calls... $BCRX - Also heavily long May calls here ($4)... stock currently trading @ $3.77 - Up 14-15% (despite recent mixed shelf filing) making it the top virus player, today - Report on the 6th. - My kind of chart! Momentum strong - Back above VWAP.
- AdrenalineTrade: $BCRX 15 minute chart. Watch that breakout. Nice volume.
- AdrenalineTrade: $BCRX Feels like it's gonna squeeze for a while. Anyone in this with me?
- Sher: $BCRX - Rebounding nicely after being smacked down following neg. report about $GILD's vaccine - Why, I have no idea, since their vaccines are dissimilar... logic doesn't seem to be a prevailing theme, lately. Co. reports on the 6th., B/O - Long May calls and adding – Expect I’ll be out of all prior to earnings.
- AdrenalineTrade: @Sher $BCRX $GILD.....Nice pullback into support, rising 12ema above 26ema. Took a piece at 3.23. Not ideal entry so small position.
- Danzguy: @Sher $BCRX $GILD Heard on CNBC the WHO posted a study that was cancelled in China due to low participation rate and people sold off. Was not a good reason to sell from what i understand. $GILD
- Sher: $BCRX - Up 19% pre-market - Long May $3.00 calls...
-
Sher: $BCRX, $CANF, $INO, $VXRT – Microcaps with strong COVID potential – Well-defined squeezes underway… Long via calls ($BCRX & $INO); Long stock ($CANF & $VXRT)
$SNY – Just added this to the above coronavirus plays - MA ... - jr3345: @Sher $BCRX $CANF $INO $VXRT $SNY thanks, very informative
- Sher: @jr3345 $BCRX $CANF $INO $VXRT $SNY - You're welcome...
- captron: @Sher $BCRX $CANF $INO $VXRT $SNY Thank you Sher. Your research has always been useful and rewarding. Have a great weekend.
- Sher: @captron $BCRX $CANF $INO $VXRT $SNY - You, as well... and thank you for your post.
- Kid2old: @Sher $BCRX $CANF $INO $VXRT $SNY Thank you for the recap. I will consider these companies after this weekend’s research. By the way I follow some of your post, but I do not do options, I just buy the shares. I have done a few covered calls in the past, as suggested in the forum by members. I am looking at the “sell the put at the price you want to buy at”.
- Sher: $CANF, $INO - Top COVID performers, pre-market: $INO update: Inovio up 7% premarket on grant for COVID-19 vaccine Apr. 16, 2020 7:14 AM ET|About: Inovio Pharmaceuticals, Inc. (INO)|By: Mamta Mayani, SA News Editor Inovio Pharmaceuticals (NASDAQ:INO) has been granted $6.9M funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to work with The International Vaccine Institute (IVI) and the Korea National Institute of Health for a Phase 1/2 clinical trial of Inovio's COVID-19 vaccine candidate (INO-4800) in South Korea. The company's DNA vaccine platform was one of the first technologies to receive support from CEPI to accelerate a COVID-19 vaccine. Korea had previously announced that it will adopt a fast-track approval process for COVID-19 vaccine and treatment clinical trials. Long $BCRX, $CANF and $VXRT - All are biotechs developing COVID vaccines...
- sierramp: @Sher $CANF $INO $BCRX $VXRT I like what $INO is doing. I hope they are successful. Do you prefer it over $VXRT? $VXRT fundies look pretty darn good for a $83M cap business.
- bill52: $BCRX I have a small position in this and just noted it's up 32% after hours. The reason: Press release just came out that they are beginning clinical trials with one of their drugs as a COVID 19 treatment. This stock has a history of crazy swings, but currently at the low end of the cycle so may have room to run on the hype. This could be another virus related run-up stock so I'm just looking for a quick pop as these things never seem to last more than a few days. I guess we'll see on Monday how it starts to plays out but I wanted to share if you want to check it out. Here's the press link: https://finance.yahoo.com/news/biocryst-begins-clinical-trial-galidesivir-204510318.html
- indigo1948: @bill52 $BCRX - thanks for the news - own a small position that I had forgotten about (bad) but will take any good news on it.
- scottrades: @mopick #CoronaVirus I took some $BCRX as a momentum trade.
-
Ajax4Hire: ...
$ABT $ABUS $ACIA $ADRO $AEM $AFL $AGCO $AGX $AIG $ALGN $ALKS $ALL $AMP $AMT $ANAB $ANF $ANTM $AOBC $APA $APT $APYX $ASH $ASIX $AYI $BAX $BCRX $BEAT $BIDU $BIIB $BKD $BKNG $BLMN $BLOK $BMY $BOOM $CACC $CALA $CARS $CCI $CDE $CELG $CENT $CGEN $CHK $CLV ... - Aragorn: @Ajax4Hire $ABT $ABUS $ACIA $ADRO $AEM $AFL $AGCO $AGX $AIG $ALGN $ALKS $ALL $AMP $AMT $ANAB $ANF $ANTM $AOBC $APA $APT $APYX $ASH $ASIX $AYI $BAX $BCRX $BEAT $BIDU $BIIB $BKD $BKNG $BLMN $BLOK $BMY $BOOM $CACC $CALA $CARS $CCI $CDE $CELG $CENT $CGEN ...
- woodman: $BCRX - on the upswing generally. Completed a bowl/cup in late Nov., then a little pullback, and now rising again the last few weeks.
- spmeyers: @vfr777 $hznp also $BCRX, though no buyers just yet
- mradams0621: $BCRX It's been working, and I hate to give up on it as it is bouncing a bit off the low of the day trying to get back above the lower bol. band with the 50 day just overhead but todays low was below the neckline completing a H&S pattern so I guess it's time to go. Any thoughts and second opinions would be appreciated.
- mradams0621: $BCRX very wild ride this morning. Can't understand the sell off on what looks like good phase I results.
- mradams0621: $BCRX phase 2?
- mradams0621: $BCRX breakout with volume but resting today still above upper B.B.
- mradams0621: $BCRX e's run still going. B.O. on 6mo chart. Nice bowl forming on 2yr chart. Plenty room to move higher before major resistance. I like it a lot. Volume increasing also.
- mradams0621: $BCRX announcement of secondary knocked it down for 3 days but with the recent good news flow and upgrades I'm thinking of adding to a small starter position. Holding VWAP on the daily at 50 ema support. Thinly traded but volume above average. Any thoughts?
- mharps: $BCRX spec staarter
- mharps: $BCRX back from the dead maybe
- mharps: $BCRX added a tiny bit to this small position-no idea what will happen
- Bridget: @issues $BCRX you are right, this definitely got a hair cut. Also why I started with a small position. I haven't sold yet since it is clear that the downtrend was broken but I'm waiting for another bounce to add. Could turn into a gap and crap. Stop at $5.
- issues: Bridget if you liked $BCRX yesterday when it was over $7 you probably really like it today down 17%. The stocks under $20 are much more volatile than those over $20. Of course there are exceptions but generally it's safer to buy after a stock has proven itself. NP But we appreciate your suggestions Bridget! Thanks for all you do for us "home gamers." Thank you Woodie for your recommendations. I finally bought a starter in $MZOR! Hurray. Haven't been convinced to pull the trigger on $GMED since it can't break above the 20 day.
- Bridget: $BCRX nice breakout and now consolidating at $7 near the 50DMA. IV has gone down significantly. I'm starting a position here.
- efrain007: @Bridget $BCRX What did you mean by 'IV has gone down significantly'?
- Bridget: @efrain007 $BCRX The IV on 5/17 was 127, now it's 93. The IV rank is also 24% which means that it is relatively low for this stock. It means there is not as much uncertainty/risk as there usually is, which for a biotech stock is good. It gives me more confidence that I won't get hit by some unexpected news soon. I like this chart with a bounce after a long pullback to support.
- efrain007: @Bridget $BCRX Got it, thanks for the info :)
- indigo1948: @Bridget $BCRX - reason for nice move: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced results from a second interim analysis of its Phase 2 APeX-1 clinical trial in hereditary angioedema (HAE). APeX-1 is a 3-part dose ranging trial designed to evaluate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered once-daily (QD) BCX7353 for 28 days, as a preventative treatment to reduce the frequency of attacks in HAE patients.
- Bridget: $BCRX has pulled back to the 50MA. We'll see if it holds here.
- DAN: @Bridget $BCRX Pretty steep pullback.
Stock Price | $4.16 |
Change | 0.00% |
Volume | 2,309,940 |
BioCryst Pharmaceuticals is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases.
Request Video of BCRXAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.69 300.35%
-
$12.63 261.95%
-
$6.39 139.73%
Past Month
Lagging Peers
-
$27.55 -81.53%
-
$6.16 -76.82%
-
$13.73 -58.64%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!